Loading...
FRESENIUS KABI DEUTSCHLAND GMBH — Docetaxel Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #3 buyer for Docetaxel · $2.4M import value · 144 shipments · GERMANY · DGFT Verified
FRESENIUS KABI DEUTSCHLAND GMBH is the #3 importer of Docetaxel from India with $2.4M in import value and 144 verified shipments. FRESENIUS KABI DEUTSCHLAND GMBH holds a 6.4% market share in Docetaxel imports based in GERMANY. The company sources from 1 verified supplier across 103 formulations shipped to 1 country. Overall, FRESENIUS KABI DEUTSCHLAND GMBH imports 10 pharmaceutical products worth $65.5M across 2 therapeutic categories.
Verified from 144 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | $2.4M | 144 | 100.0% |
FRESENIUS KABI DEUTSCHLAND GMBH sources Docetaxel from 1 verified Indian supplier based on 144 customs records. The primary supplier is FRESENIUS KABI ONCOLOGY LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN INSTITUTIONAL INC 2898 | UNITED STATES | $3.3M | 65 | $50.0K |
| 3 | FRESENIUS KABI DEUTSCHLAND GMBH ★ | GERMANY | $2.5M | 144 | $17.5K |
| 7 | FRESENIUS KABI COLOMBIA SAS | COLOMBIA | $1.1M | 28 | $39.1K |
| 10 | CPC "BIOCON" LLC | UKRAINE | $707.3K | 18 | $39.3K |
FRESENIUS KABI DEUTSCHLAND GMBH ranks #3 among 641 Docetaxel importers from India. Average shipment value of $17.5K compared to the market average of $19.4K. The closest competitors by value are MYLAN INSTITUTIONAL INC 2898 and FRESENIUS KABI COLOMBIA SAS.
Destination countries from 144 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $2.4M | 144 | 100.0% |
FRESENIUS KABI DEUTSCHLAND GMBH imports Docetaxel to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $2.4M.
| Formulation | Value | Shipments |
|---|---|---|
| DOCETAXEL KABI INJECTION 80MG/4ML VIAL B | $189.7K | 11 |
| DOCETAXEL KABI INJ. 160MG/8ML VIAL,BATC | $110.1K | 5 |
| DOCETAXEL KABI INJ. 160MG/8ML VIAL Ite | $95.2K | 5 |
| DOCETAXEL KABI INJ. 80MG/4ML VIAL Item | $82.0K | 7 |
| DOCETAXEL KABI INJ. 160MG/8ML VIAL B/N:8 | $69.4K | 3 |
| DOCETAXEL KABI INJ. 160MG/8ML VIAL (Ite | $55.2K | 4 |
| DOCETAXEL KABI INJ 160MG 8ML VIALBATCH NO 87230090AAMFG DT 02 2023 EXP DT 01 2025 | $50.0K | 1 |
| DOCETAXEL KABI INJ.160MG/8ML VIAL B.NO.87230243AA MANUFACTURING .DT.05/2023EXP.DT.04/2025 | $50.0K | 1 |
| DOCETAXEL KABI INJ.160MG/8ML VIAL B.NO.87230398AB MANUFACTURING .DT.08/2023EXP.DT.07/2025 |
What FRESENIUS KABI DEUTSCHLAND GMBH and other importers must comply with to import Docetaxel from India
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
India exported $12.4M worth of Docetaxel through 2,634 shipments from 253 suppliers to 120 countries, serving 641 buyers globally. FRESENIUS KABI DEUTSCHLAND GMBH imports $2.4M of this total, accounting for 6.4% of India's Docetaxel exports with 144 shipments from GERMANY. This is verified from 144 customs shipment records covering 103 distinct formulations.
FRESENIUS KABI DEUTSCHLAND GMBH's average Docetaxel order value is $16.5K per consignment, based on 144 shipments totaling $2.4M. FRESENIUS KABI DEUTSCHLAND GMBH is based in GERMANY and ranks #3 among all Docetaxel importers from India by value. The company sources from 1 verified supplier in India.
FRESENIUS KABI DEUTSCHLAND GMBH sources Docetaxel from 1 verified Indian supplier: FRESENIUS KABI ONCOLOGY LIMITED ($2.4M, 100.0%). This is based on 144 customs records.
FRESENIUS KABI DEUTSCHLAND GMBH ranks #3 among 641 Docetaxel importers from India with a 6.4% market share. The top 3 importers are MYLAN INSTITUTIONAL INC 2898 ($3.3M), FRESENIUS KABI DEUTSCHLAND GMBH ($2.5M), FRESENIUS KABI COLOMBIA SAS ($1.1M). FRESENIUS KABI DEUTSCHLAND GMBH processed 144 shipments from GERMANY.
FRESENIUS KABI DEUTSCHLAND GMBH also imports these oncology products. Each links to the detailed product page.
FRESENIUS KABI DEUTSCHLAND GMBH imports 10 products worth $65.5M. Beyond Docetaxel, top products include Paclitaxel, Carboplatin, Oxaliplatin, Pemetrexed, Irinotecan. View the complete FRESENIUS KABI DEUTSCHLAND GMBH profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Docetaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI DEUTSCHLAND GMBH's Docetaxel imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI DEUTSCHLAND GMBH
Full Company Profile →
10 products · $65.5M total trade · 2 categories
| $50.0K |
| 1 |
| DOCETAXEL KABI INJ.120MG/6ML VIAL B.NO.87230427AA MANUFACTURING .DT.09/2023EXP.DT.08/2025 | $50.0K | 1 |
FRESENIUS KABI DEUTSCHLAND GMBH imports 103 distinct Docetaxel formulations from India. The top formulation is DOCETAXEL KABI INJECTION 80MG/4ML VIAL B with 11 shipments worth $189.7K.
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 120+ countries, 641+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI DEUTSCHLAND GMBH.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Docetaxel. For current order-level data, contact TransData Nexus.